Paradigm Biocapital Advisors LP 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Sale | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Paradigm Biocapital Advisors LP | 0 0.000% | -399,658 (Position Closed) | Filing |
| 2024-02-05 4:21 pm Purchase | 2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Paradigm Biocapital Advisors LP | 399,658 9.000% | 399,658 (New Position) | Filing |